These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome. Watts GF; Chan DC; Barrett PH; O'Neill FH; Thompson GR Int J Obes Relat Metab Disord; 2003 Jul; 27(7):862-5. PubMed ID: 12821974 [TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly. Evidence that hydrophobic sequences within apolipoprotein B48 mediate lipid recruitment. McLeod RS; Wang Y; Wang S; Rusiñol A; Links P; Yao Z J Biol Chem; 1996 Aug; 271(31):18445-55. PubMed ID: 8702489 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231 [TBL] [Abstract][Full Text] [Related]
45. Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency. Cummings MH; Christ E; Umpleby AM; Albany E; Wierzbicki A; Lumb PJ; Sönksen PH; Russell-Jones DL J Clin Endocrinol Metab; 1997 Jun; 82(6):2010-3. PubMed ID: 9177423 [TBL] [Abstract][Full Text] [Related]
46. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Mittendorfer B; Patterson BW; Klein S Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E549-56. PubMed ID: 12475754 [TBL] [Abstract][Full Text] [Related]
47. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523 [TBL] [Abstract][Full Text] [Related]
48. Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Ng TW; Watts GF; Farvid MS; Chan DC; Barrett PH Diabetes; 2005 Mar; 54(3):795-802. PubMed ID: 15734858 [TBL] [Abstract][Full Text] [Related]
49. Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat. Zheng C; Ikewaki K; Walsh BW; Sacks FM J Lipid Res; 2006 Aug; 47(8):1771-9. PubMed ID: 16685082 [TBL] [Abstract][Full Text] [Related]
50. CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia. Song Y; Zhao M; Cheng X; Shen J; Khound R; Zhang K; Su Q J Mol Med (Berl); 2017 Aug; 95(8):839-849. PubMed ID: 28455595 [TBL] [Abstract][Full Text] [Related]
52. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Chan DC; Watts GF; Nguyen MN; Barrett PH Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456 [TBL] [Abstract][Full Text] [Related]
53. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202 [TBL] [Abstract][Full Text] [Related]
54. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. Parhofer KG; Hugh P; Barrett R; Bier DM; Schonfeld G J Lipid Res; 1991 Aug; 32(8):1311-23. PubMed ID: 1770313 [TBL] [Abstract][Full Text] [Related]
55. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386 [TBL] [Abstract][Full Text] [Related]
57. Abundance of mRNA of apolipoprotein b100, apolipoprotein e, and microsomal triglyceride transfer protein in liver from periparturient dairy cows. Bernabucci U; Ronchi B; Basiricò L; Pirazzi D; Rueca F; Lacetera N; Nardone A J Dairy Sci; 2004 Sep; 87(9):2881-8. PubMed ID: 15375048 [TBL] [Abstract][Full Text] [Related]
58. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity. Pont F; Duvillard L; Florentin E; Gambert P; Vergès B Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756 [TBL] [Abstract][Full Text] [Related]
59. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Venkatesan S; Cullen P; Pacy P; Halliday D; Scott J Arterioscler Thromb; 1993 Jul; 13(7):1110-8. PubMed ID: 8318511 [TBL] [Abstract][Full Text] [Related]
60. Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans. Prinsen BH; Romijn JA; Bisschop PH; de Barse MM; Barrett PH; Ackermans M; Berger R; Rabelink TJ; de Sain-van der Velden MG J Lipid Res; 2003 Jul; 44(7):1341-8. PubMed ID: 12700338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]